History of Chugai Pharmaceutical
Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”
- Foundation - 1939
- 1940 - 1959
- 1960 - 1979
- 1980 - 1999
- 2000 - 2019
- 2020 -
Chugai merged with Nippon Roche in 2002 based on a strategic alliance agreement with Roche.
- History of Chugai Pharmaceutical
- History of Nippon Roche
Constructed a general research laboratory (Takada Research Laboratory, Tokyo) (Sep.)
Constructed Ohta Plant
Start of the collaborative research with Kanazawa University on OK-432(now “Picibanil®) that activates immunological cells
Kimio Ueno appointed as Representative Director and President (Apr.)
Hiring of university graduate started on regular basis
Established Fukushima Kasei Co., Ltd. (Oct.)
Relocated headquarters to the Kokusai Building in Tokyo;
Constructed Kamakura Plant (Kanagawa Prefecture)
The company name changed to Eiko Kasei Co., Ltd. following the merger of Fukushima Kasei Co., Ltd. and Fukuma Kasei Co., Ltd. (Nov.)
J.J. de Pury appointed as Representative Director and President
Constructed the Fujieda Plant (Shizuoka Prefecture) (Mar.)
Constructed Fukuroi Plant (Shizuoka Prefecture); Established Diagnostics Division
A.F. Leuenberger appointed as Representative Director and President
Launched Picibanil®, an anti-cancer agent and anti-lymphangioma agent (Oct.)
- Foundation - 1939
- 1940 - 1959
- 1960 - 1979
- 1980 - 1999
- 2000 - 2019
- 2020 -
